SPONSORS & PARTNERS

Thank you to our sponsors and media partners for their generosity and support in raising epilepsy awareness throughout the June 2017 Epilepsy Blog Relay™.

Founding Sponsor

Sunovion

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Brovana® (arformoterol tartrate), Latuda® (lurasidone HCI), and most recently Aptiom® (eslicarbazepine acetate).

Headquartered in Marlborough, Mass. Sunovion is an indirect, wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc. Additional information can be found on the Company’s web sites: www.sunovion.com, www.sunovion.eu and www.sunovion.ca. Connect with Sunovion on Twitter @Sunovion and LinkedIn.

LATUDA is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd.

APTIOM is used under license from BIAL.

BROVANA is a registered trademark of Sunovion Pharmaceuticals Inc.

© 2015 Sunovion Pharmaceuticals Inc.


Become a Sponsor

If you are interested in sponsoring a future Epilepsy Blog Relay contact Jessica Keenan Smith, Founder of Living Well With Epilepsy, via email at info@livingwellwithepilepsy.com.

Become a November 2017 Sponsor